Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Klengel, D. Mehta, C. Anacker, M. Rex-Haffner, J. Pruessner, C. Pariante, Thaddeus Pace, Kristina Mercer, H. Mayberg, B. Bradley, C. Nemeroff, F. Holsboer, C. Heim, K. Ressler, T. Rein, E. Binder (2012)
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactionsNature Neuroscience, 16
K. Kovács, A. Földes, P. Sawchenko (2000)
Glucocorticoid Negative Feedback Selectively Targets Vasopressin Transcription in Parvocellular Neurosecretory NeuronsThe Journal of Neuroscience, 20
Xinyu Zhang, A. Clark, T. Yorio (2008)
FK506-Binding Protein 51 Regulates Nuclear Transport of the Glucocorticoid Receptor (cid:1) and Glucocorticoid Responsiveness
H. Vermeer, B. Hendriks-Stegeman, B. Burg, S. Buul-Offers, M. Jansen (2003)
Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.The Journal of clinical endocrinology and metabolism, 88 1
A. Buchmann, N. Holz, R. Boecker, Dorothea Blomeyer, M. Rietschel, S. Witt, Martin Schmidt, G. Esser, T. Banaschewski, D. Brandeis, U. Zimmermann, M. Laucht (2014)
Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthoodEuropean Neuropsychopharmacology, 24
A. Roy, E. Gorodetsky, Qiaoping Yuan, D. Goldman, M. Enoch (2010)
Interaction of FKBP5, a Stress-Related Gene, with Childhood Trauma Increases the Risk for Attempting SuicideNeuropsychopharmacology, 35
A. Szczepankiewicz, A. Leszczynska-rodziewicz, J. Pawlak, B. Narożna, A. Rajewska-Rager, M. Wilkosc, D. Zaremba, M. Maciukiewicz, J. Twarowska-Hauser (2014)
FKBP5 polymorphism is associated with major depression but not with bipolar disorder.Journal of affective disorders, 164
O. Levran, E. Peles, M. Randesi, Yi Li, J. Rotrosen, Jurg Ott, Jurg Ott, M. Adelson, M. Kreek (2014)
Stress-related genes and heroin addiction: A role for a functional FKBP5 haplotypePsychoneuroendocrinology, 45
K. Koenen, M. Uddin (2010)
FKBP5 Polymorphisms Modify the Effects of Childhood TraumaNeuropsychopharmacology, 35
E. Binder, D. Salyakina, P. Lichtner, G. Wochnik, M. Ising, B. Pütz, S. Papiol, S. Seaman, S. Lucae, M. Kohli, T. Nickel, H. Künzel, B. Fuchs, M. Majer, A. Pfennig, N. Kern, J. Brunner, S. Modell, T. Baghai, T. Deiml, P. Zill, B. Bondy, R. Rupprecht, T. Messer, O. Köhnlein, Heike Dabitz, T. Brückl, N. Müller, H. Pfister, R. Lieb, Jakob Mueller, E. Lõhmussaar, T. Strom, T. Bettecken, T. Meitinger, M. Uhr, T. Rein, F. Holsboer, Bertram Muller-Myhsok (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentNature Genetics, 36
T. Heatherton, L. Kozlowski, R. Frecker, K. Fagerström (1991)
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.British journal of addiction, 86 9
J. Saunders, O. Aasland, T. Babor, J. Fuente, M. Grant (1993)
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.Addiction, 88 6
D. Brent, N. Melhem, R. Ferrell, G. Emslie, K. Wagner, N. Ryan, B. Vitiello, B. Birmaher, T. Mayes, Jamie Zelazny, Matthew Onorato, B. Devlin, G. Clarke, L. DeBar, M. Keller (2010)
Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.The American journal of psychiatry, 167 2
E. Binder, R. Bradley, Wei Liu, M. Epstein, T. Deveau, Kristina Mercer, Yilang Tang, Charles Gillespie, C. Heim, C. Nemeroff, Ann Schwartz, J. Cubells, K. Ressler (2008)
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.JAMA, 299 11
Ming-Chyi Huang, M. Schwandt, J. Chester, Aaron Kirchhoff, C. Kao, Tiebing Liang, Jenica Tapocik, V. Ramchandani, D. George, C. Hodgkinson, D. Goldman, M. Heilig (2014)
FKBP5 Moderates Alcohol Withdrawal Severity: Human Genetic Association and Functional Validation in Knockout MiceNeuropsychopharmacology, 39
W. Pratt, Y. Morishima, M. Murphy, M. Harrell (2006)
Chaperoning of glucocorticoid receptors.Handbook of experimental pharmacology, 172
C. Pomerleau, Emily Ehrlich, James Tate, J. Marks, K. Flessland, O. Pomerleau (1993)
The female weight-control smoker: a profile.Journal of substance abuse, 5 4
(1995)
Beckdepressions-inventar (BDI). Testhandbuch. (2. überarbeitete Auflage)
P. Zimmermann, T. Brückl, A. Nocon, H. Pfister, E. Binder, M. Uhr, R. Lieb, T. Moffitt, A. Caspi, F. Holsboer, M. Ising (2011)
Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study.The American journal of psychiatry, 168 10
J. Sarginson, L. Lazzeroni, Heather Ryan, A. Schatzberg, G. Murphy (2010)
FKBP5 polymorphisms and antidepressant response in geriatric depressionAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B
J. Sarginson, L. Lazzeroni, Heather Ryan, B. Ershoff, A. Schatzberg, G. Murphy (2010)
ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depressionPharmacogenetics and Genomics, 20
A. Minelli, E. Maffioletti, C. Cloninger, C. Magri, R. Sartori, M. Bortolomasi, C. Congiu, S. Bignotti, M. Segala, M. Giacopuzzi, M. Gennarelli (2013)
ROLE OF ALLELIC VARIANTS OF FK506‐BINDING PROTEIN 51 (FKBP5) GENE IN THE DEVELOPMENT OF ANXIETY DISORDERSDepression and Anxiety, 30
M. Lekman, G. Laje, D. Charney, A. Rush, Alexander Wilson, A. Sorant, Robert Lipsky, S. Wisniewski, H. Manji, F. McMahon, Silvia Paddock (2008)
The FKBP5-Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) CohortBiological Psychiatry, 63
Takashi Fujii, H. Hori, M. Ota, K. Hattori, T. Teraishi, D. Sasayama, Noriko Yamamoto, T. Higuchi, H. Kunugi (2014)
Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expressionPsychoneuroendocrinology, 42
G. Wochnik, J. Rüegg, G. Abel, U. Schmidt, F. Holsboer, T. Rein (2005)
FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells*Journal of Biological Chemistry, 280
J. Pérez‐Ortiz, M. García-Gutiérrez, F. Navarrete, S. Giner, J. Manzanares (2013)
Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victimsPsychoneuroendocrinology, 38
Sheldon Cohen, T. Kamarck, R. Mermelstein (1983)
A global measure of perceived stress.Journal of health and social behavior, 24 4
(1991)
Deutsche version des Fagerström-test for nicotine dependence (FTND-G) und des heaviness of smoking index (HSI-G). In: Elektronisches handbuch zu erhebungsinstrumenten im suchtbereich (EHES). Version
Katja Appel, C. Schwahn, J. Mahler, A. Schulz, C. Spitzer, Kristin Fenske, J. Stender, S. Barnow, U. John, A. Teumer, R. Biffar, M. Nauck, H. Völzke, H. Freyberger, H. Grabe (2011)
Moderation of Adult Depression by a Polymorphism in the FKBP5 Gene and Childhood Physical Abuse in the General PopulationNeuropsychopharmacology, 36
W. Pratt, D. Toft (1997)
Steroid receptor interactions with heat shock protein and immunophilin chaperones.Endocrine reviews, 18 3
A. Koopmann, C. Dinter, M. Grosshans, C. Goltz, R. Hentschel, N. Dahmen, J. Gallinat, M. Wagner, G. Gründer, N. Thürauf, T. Wienker, J. Brinkmeyer, A. Mobascher, K. Spreckelmeyer, M. Clepce, W. Millas, K. Wiedemann, G. Winterer, F. Kiefer (2011)
Psychological and hormonal features of smokers at risk to gain weight after smoking cessation — Results of a multicenter studyHormones and Behavior, 60
C. Spielberger, R. Gorsuch, R. Lushene (1970)
STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire")
M. Gawlik, Kerstin Moller-Ehrlich, M. Mende, Michael Jovnerovski, S. Jung, B. Jabs, M. Knapp, G. Stoeber (2006)
Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traitsBMC Psychiatry, 6
A. Beck, C. Ward, M. Mendelson, J. Mock, J. Erbaugh (1961)
An inventory for measuring depression.Archives of general psychiatry, 4
H. Wittchen, M. Zaudig, T. Fydrich (1997)
SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Handanweisung
E. Binder (2009)
The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disordersPsychoneuroendocrinology, 34
G. Shinozaki, S. Jowsey, H. Amer, Joanna Biernacka, C. Colby, D. Walker, J. Black, J. Rundell, M. Stegall, D. Mrazek (2011)
Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipientsDepression and Anxiety, 28
K. Koenen, K. Koenen, Glenn Saxe, Glenn Saxe, Shaun Purcell, Jordan Smoller, D. Bartholomew, Alisa Miller, Alisa Miller, Erin Hall, Erin Hall, Julie Kaplow, Michelle Bosquet, Michelle Bosquet, Steve Moulton, Clinton Baldwin (2005)
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured childrenMolecular Psychiatry, 10
Adrienne VanZomeren-Dohm, Clio Pitula, Kalsea Koss, K. Thomas, M. Gunnar (2015)
FKBP5 moderation of depressive symptoms in peer victimized, post-institutionalized childrenPsychoneuroendocrinology, 51
M. Ising, Anna Depping, A. Siebertz, S. Lucae, P. Unschuld, S. Kloiber, S. Horstmann, M. Uhr, B. Müller-Myhsok, F. Holsboer (2008)
Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controlsEuropean Journal of Neuroscience, 28
Pingxing Xie, H. Kranzler, James Poling, M. Stein, R. Anton, L. Farrer, J. Gelernter (2010)
Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress DisorderNeuropsychopharmacology, 35
R. Hauger, J. Olivares-Reyes, F. Dautzenberg, J. Lohr, S. Braun, R. Oakley (2012)
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapyNeuropharmacology, 62
Summary Tobacco smoking modulates activity in the hypothalamic‐pituitary‐adrenal (HPA) axis and is used to cope with stress, especially by females. The single nucleotide polymorphism (SNP) rs1360780, linked to FK506‐binding protein 51 (FKBP5), has been shown to affect HPA axis functioning, and has thus been suggested as a promising candidate for indicating vulnerability to stress‐related disorders. The aim of this study was to investigate the interaction between nicotine consumption and rs1360780 on cortisol plasma levels in females. A total of 296 female smokers (assessed by the Fagerström Test for Nicotine Dependence; FTND) were genotyped for the SNP rs1360780. We measured participants’ cortisol plasma concentration in blood plasma collected 3 h after standardized tobacco smoking exposure. In the 36 TT‐homozygotes, we found a significant negative correlation between the FTND sum score and cortisol plasma concentrations. Using linear regression analysis, we found that the FTND sum score accounted for 12.4% of the variance of cortisol plasma levels. This association was not detected in C‐allele carriers. Our results suggest that nicotine is an important confounder in the modulation of HPA axis activity by FKBP5. In light of these findings, future studies on FKBP5 should seek to include data on nicotine consumption as a covariate.
Annals of Human Genetics – Wiley
Published: May 1, 2016
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.